Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery

NCT02201771 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Bypass
Antiplatelet Agents

Interventions

DRUG: Aspirin
DRUG: Ticagrelor

Sponsor

Ruijin Hospital